Advertisement
BSX vs MDT
Which Stock Would AI Choose? Boston Scientific (BSX) vs. Medtronic (MDT) Stock Comparison
Key Takeaways
- BSX and MDT are both leading medical device companies focused on cardiovascular, structural heart, and neuromodulation solutions, with overlapping yet differentiated product portfolios.
- In recent market activity, BSX has shown stronger revenue growth momentum from its Q1 2026 results but faced multiple analyst price target reductions amid concerns over certain segments.
- MDT has demonstrated relative price stability compared to broader sector volatility, supported by consistent procedure volumes and a dividend yield, though it contends with ongoing product litigation.
- Sector exposure for both centers on healthcare innovation and aging demographics, with BSX exhibiting higher growth orientation and MDT offering greater scale and income characteristics.
- Market sentiment reflects constructive long-term outlooks for medical devices, tempered by near-term regulatory and competitive pressures affecting relative performance.
- Upcoming catalysts include BSX’s Q2 earnings report, while MDT continues to navigate legal developments in its legacy product lines.
Introduction
Boston Scientific Corporation (BSX) and Medtronic plc (MDT) represent two prominent players in the global medical devices industry. This comparison examines their recent performance, business positioning, and market dynamics to assist traders and investors evaluating healthcare equities. Participants seeking exposure to innovation-driven growth, procedural volume trends, and relative valuation within the medtech sector may find this analysis relevant for portfolio construction or tactical allocation decisions in the current environment.
BSX Overview and Recent Performance
Boston Scientific Corporation develops and manufactures medical devices primarily in cardiovascular, rhythm management, endoscopy, and peripheral interventions. In recent weeks, BSX shares have experienced volatility amid a series of analyst price target adjustments, with several firms lowering targets while maintaining buy ratings. The company reported solid first-quarter 2026 results with double-digit sales growth, and attention now centers on its upcoming second-quarter earnings release. Broader market activity has reflected mixed sentiment influenced by sector rotation and specific product segment considerations.
MDT Overview and Recent Performance
Medtronic plc is a diversified medical technology company with leadership positions in cardiovascular, medical-surgical, neuroscience, and diabetes care. In recent market activity, MDT has shown comparatively steadier price behavior relative to some peers, supported by ongoing procedural demand. The company has faced legal proceedings related to certain legacy hernia mesh products. Recent trading sessions have reflected incremental gains in select periods, consistent with broader healthcare sector movements and company-specific operational updates.
Trending AI Robots
Tickeron’s Trending AI Robots page showcases a curated selection of AI trading bots optimized for prevailing market conditions. Tickeron offers hundreds of AI Trading Bots capable of trading thousands of different tickers across equities, options, and other instruments. Only the highest-performing and most suitable bots for current environments earn placement in this trending section. Available bots span a wide range of trading styles, strategies, timeframes, and performance statistics, with historical win rates and returns varying by configuration. This resource provides traders with transparent data on bot metrics to inform automated strategy selection. Explore the full curated list on the Trending AI Robots page.
Head-to-Head Comparison
BSX emphasizes higher-growth segments with recent revenue expansion exceeding double digits in the latest reported quarter, while MDT benefits from greater overall scale and diversified revenue streams across multiple therapeutic areas. Growth drivers for BSX include structural heart and electrophysiology innovations, whereas MDT draws strength from established cardiovascular and neuromodulation platforms. Recent momentum has favored BSX on earnings beats but introduced more price volatility; MDT has displayed relative resilience amid sector fluctuations. Risk factors for BSX include potential regulatory scrutiny on specific devices, while MDT navigates product liability matters. Both maintain significant exposure to the medical devices sector, with market sentiment remaining generally constructive on long-term demographic tailwinds yet attentive to valuation and competitive dynamics.
Tickeron AI Verdict
Based on observable factors such as trend consistency, earnings visibility, and relative positioning within the medical devices sector, Tickeron’s AI would currently assign a modestly higher probabilistic preference to BSX for growth-oriented profiles, while acknowledging MDT’s advantages in stability and income characteristics. This assessment reflects recent performance patterns and sector catalysts without implying certainty of future outcomes.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSX is a Hold and MDT is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BSX’s FA Score shows that 0 FA rating(s) are green whileMDT’s FA Score has 1 green FA rating(s).
- BSX’s FA Score: 0 green, 5 red.
- MDT’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BSX’s TA Score shows that 6 TA indicator(s) are bullish while MDT’s TA Score has 5 bullish TA indicator(s).
- BSX’s TA Score: 6 bullish, 2 bearish.
- MDT’s TA Score: 5 bullish, 3 bearish.
Price Growth
BSX (@Medical/Nursing Services) experienced а +3.98% price change this week, while MDT (@Medical/Nursing Services) price change was +1.12% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -3.06%. For the same industry, the average monthly price growth was -7.81%, and the average quarterly price growth was -14.13%.
Reported Earning Dates
BSX is expected to report earnings on Jul 29, 2026.
MDT is expected to report earnings on Sep 01, 2026.
Industries' Descriptions
@Medical/Nursing Services (-3.06% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| BSX | MDT | BSX / MDT | |
| Capitalization | 67.6B | 108B | 63% |
| EBITDA | 5.49B | 9.81B | 56% |
| Gain YTD | -52.271 | -10.812 | 483% |
| P/E Ratio | 19.04 | 22.58 | 84% |
| Revenue | 20.6B | 36.4B | 57% |
| Total Cash | 1.45B | 9.22B | 16% |
| Total Debt | 11B | 28B | 39% |
BSX | MDT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 65 | 29 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 61 Fair valued | 3 Undervalued | |
PROFIT vs RISK RATING 1..100 | 97 | 100 | |
SMR RATING 1..100 | 58 | 72 | |
PRICE GROWTH RATING 1..100 | 65 | 57 | |
P/E GROWTH RATING 1..100 | 98 | 63 | |
SEASONALITY SCORE 1..100 | 50 | 55 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MDT's Valuation (3) in the Medical Specialties industry is somewhat better than the same rating for BSX (61). This means that MDT’s stock grew somewhat faster than BSX’s over the last 12 months.
BSX's Profit vs Risk Rating (97) in the Medical Specialties industry is in the same range as MDT (100). This means that BSX’s stock grew similarly to MDT’s over the last 12 months.
BSX's SMR Rating (58) in the Medical Specialties industry is in the same range as MDT (72). This means that BSX’s stock grew similarly to MDT’s over the last 12 months.
MDT's Price Growth Rating (57) in the Medical Specialties industry is in the same range as BSX (65). This means that MDT’s stock grew similarly to BSX’s over the last 12 months.
MDT's P/E Growth Rating (63) in the Medical Specialties industry is somewhat better than the same rating for BSX (98). This means that MDT’s stock grew somewhat faster than BSX’s over the last 12 months.
| BSX | MDT | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 46% | N/A |
| Stochastic ODDS (%) | 1 day ago 56% | 1 day ago 48% |
| Momentum ODDS (%) | 1 day ago 60% | 1 day ago 52% |
| MACD ODDS (%) | 5 days ago 64% | 1 day ago 53% |
| TrendWeek ODDS (%) | 1 day ago 55% | 1 day ago 53% |
| TrendMonth ODDS (%) | 1 day ago 55% | 1 day ago 46% |
| Advances ODDS (%) | 1 day ago 57% | 1 day ago 51% |
| Declines ODDS (%) | 7 days ago 55% | 7 days ago 57% |
| BollingerBands ODDS (%) | 6 days ago 57% | 1 day ago 68% |
| Aroon ODDS (%) | 1 day ago 68% | 1 day ago 36% |
Advertisement
MDT and
Correlation & Price change
A.I.dvisor indicates that over the last year, MDT has been loosely correlated with SYK. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if MDT jumps, then SYK could also see price increases.